FindTrial
Sign In

A retrospective and prospective observational study on the clinical features, immunotherapy and long-term prognosis of autoimmune encephalitis

A retrospective and prospective observational study on the clinical features, immunotherapy and long-term prognosis of autoimmune encephalitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041175
Enrollment
Unknown
Registered
2020-12-20
Start date
2020-12-30
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmune encephalitis

Interventions

two:none

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: The diagnosis is in line with the "Consensus of Experts on Diagnosis and Treatment of Autoimmune Encephalitis in China" for patients with autoimmune encephalitis diagnosed in our hospital.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
Autoimmune encephalitis antibody;—

Countries

China

Contacts

Public ContactHuang Ying

Department of Neurogy, Shenzhen People's Hospital Jinan University

627501849@qq.com+86 15919822508

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026